129 related articles for article (PubMed ID: 38334357)
21. Functional defects in
Gupta P; Zhang Z; Sugiman-Marangos SN; Tam J; Raman S; Julien JP; Kroh HK; Lacy DB; Murgolo N; Bekkari K; Therien AG; Hernandez LD; Melnyk RA
J Biol Chem; 2017 Oct; 292(42):17290-17301. PubMed ID: 28842504
[No Abstract] [Full Text] [Related]
22. Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection.
Wang S; Zhu D; Sun X
Microbiol Spectr; 2022 Jun; 10(3):e0026322. PubMed ID: 35583336
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of the Endosomal Anion/Proton Exchanger ClC-5 Increases Cell Susceptibility toward
Ruhe F; Olling A; Abromeit R; Rataj D; Grieschat M; Zeug A; Gerhard R; Alekov A
Front Cell Infect Microbiol; 2017; 7():67. PubMed ID: 28348980
[TBL] [Abstract][Full Text] [Related]
24. Putative Conjugative Plasmids with tcdB and cdtAB Genes in Clostridioides difficile.
Ramírez-Vargas G; Rodríguez C
Emerg Infect Dis; 2020 Sep; 26(9):2287-2290. PubMed ID: 32818425
[TBL] [Abstract][Full Text] [Related]
25. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.
Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA
FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.
Li S; Shi L; Yang Z; Feng H
Pathog Dis; 2013 Feb; 67(1):11-8. PubMed ID: 23620115
[TBL] [Abstract][Full Text] [Related]
27. Subtyping analysis reveals new variants and accelerated evolution of Clostridioides difficile toxin B.
Shen E; Zhu K; Li D; Pan Z; Luo Y; Bian Q; He L; Song X; Zhen Y; Jin D; Tao L
Commun Biol; 2020 Jul; 3(1):347. PubMed ID: 32620855
[TBL] [Abstract][Full Text] [Related]
28. The microbial metabolite urolithin A reduces
Ghosh S; Erickson D; Chua MJ; Collins J; Jala VR
mSystems; 2024 Feb; 9(2):e0125523. PubMed ID: 38193707
[No Abstract] [Full Text] [Related]
29. Sequence variation in tcdA and tcdB of Clostridium difficile: ST37 with truncated tcdA is a potential epidemic strain in China.
Du P; Cao B; Wang J; Li W; Jia H; Zhang W; Lu J; Li Z; Yu H; Chen C; Cheng Y
J Clin Microbiol; 2014 Sep; 52(9):3264-70. PubMed ID: 24958798
[TBL] [Abstract][Full Text] [Related]
30. RstA Is a Major Regulator of Clostridioides difficile Toxin Production and Motility.
Edwards AN; Anjuwon-Foster BR; McBride SM
mBio; 2019 Mar; 10(2):. PubMed ID: 30862746
[No Abstract] [Full Text] [Related]
31. The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis.
Bilverstone TW; Garland M; Cave RJ; Kelly ML; Tholen M; Bouley DM; Kaye P; Minton NP; Bogyo M; Kuehne SA; Melnyk RA
PLoS Pathog; 2020 Sep; 16(9):e1008852. PubMed ID: 32960931
[TBL] [Abstract][Full Text] [Related]
32. A neutralizing antibody that blocks delivery of the enzymatic cargo of
Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB
J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448
[No Abstract] [Full Text] [Related]
33. A Streamlined Method to Obtain Biologically Active TcdA and TcdB Toxins from
Sapa D; Brosse A; Coullon H; Péan de Ponfilly G; Candela T; Le Monnier A
Toxins (Basel); 2024 Jan; 16(1):. PubMed ID: 38251254
[TBL] [Abstract][Full Text] [Related]
34. Adenosine receptors differentially mediate enteric glial cell death induced by
Costa DVS; Shin JH; Goldbeck SM; Bolick DT; Mesquita FS; Loureiro AV; Rodrigues-Jesus MJ; Brito GAC; Warren CA
Front Immunol; 2022; 13():956326. PubMed ID: 36726986
[TBL] [Abstract][Full Text] [Related]
35. Development of a non-radiolabeled glucosyltransferase activity assay for C. difficile toxin A and B using ultra performance liquid chromatography.
Loughney JW; Lancaster C; Price CE; Hoang VM; Ha S; Rustandi RR
J Chromatogr A; 2017 May; 1498():169-175. PubMed ID: 28238427
[TBL] [Abstract][Full Text] [Related]
36. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
Chen S; Sun C; Wang H; Wang J
Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
[TBL] [Abstract][Full Text] [Related]
37. Use of a neutralizing antibody helps identify structural features critical for binding of
Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
[No Abstract] [Full Text] [Related]
38. Detection and elimination of a novel non-toxigenic
Maslanka JR; Gu CH; Zarin I; Denny JE; Broadaway S; Fett B; Mattei LM; Walk ST; Abt MC
Gut Microbes; 2020 Nov; 12(1):1-15. PubMed ID: 33305657
[No Abstract] [Full Text] [Related]
39. Human α-Defensin-5 Efficiently Neutralizes
Korbmacher M; Fischer S; Landenberger M; Papatheodorou P; Aktories K; Barth H
Front Pharmacol; 2020; 11():1204. PubMed ID: 32903430
[TBL] [Abstract][Full Text] [Related]
40. Detoxification of toxin A and toxin B by copper ion-catalyzed oxidation in production of a toxoid-based vaccine against Clostridioides difficile.
Aminzadeh A; Tiwari MK; Mamah Mustapha SS; Navarrete SJ; Henriksen AB; Møller IM; Krogfelt KA; Bjerrum MJ; Jørgensen R
Free Radic Biol Med; 2020 Nov; 160():433-446. PubMed ID: 32860983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
